Molecular action of sulphonylureas on KATP channels: A real partnership between drugs and nucleotides

Biochemical Society Transactions

Volumn 43, Issue , 2015, Pages 901-907

  De Wet, Heidi ^a   Proks, Peter ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

ABCC8; Diabetes; KATP channels; Kir6.2; SUR1

Indexed keywords

ADENOSINE TRIPHOSPHATE; POTASSIUM CHANNEL; SULFONYLUREA; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; INSULIN; SULFONYLUREA DERIVATIVE;

ARTICLE; B LYMPHOCYTE; CHANNEL GATING; DIABETES MELLITUS; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME INHIBITION; EXOCYTOSIS; HUMAN; INSULIN RELEASE; MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; DRUG EFFECTS; METABOLISM; NEWBORN; PANCREAS ISLET; SECRETION (PROCESS);

ADENOSINE TRIPHOSPHATE; DIABETES MELLITUS; HUMANS; INFANT, NEWBORN; INSULIN; ION CHANNEL GATING; ISLETS OF LANGERHANS; KATP CHANNELS; MEMBRANE POTENTIALS; SULFONYLUREA COMPOUNDS;

EID: 84947241076     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20150096     Document Type: Article

References (45)

1. Thulé, P.M. and Umpierrez, G. (2014) Sulfonylureas: a new look at old therapy. Curr. Diab. Rep. 14, 473-481 CrossRef PubMed
2. Gribble, F.M. and Reimann, F. (2003) Sulphonylurea action revisited: the post-cloning era. Diabetologia 46, 875-891 CrossRef PubMed
3. Ashcroft, F.M. and Rorsman, P. (1989) Electrophysiology of the pancreatic beta-cell. Prog. Biophys. Mol. Biol. 54, 87-143 CrossRef PubMed
4. Proks, P., Reimann, F., Green, N., Gribble, F. and Ashcroft, F.M. (2002) Sulfonylurea stimulation of insulin secretion. Diabetes 51 Suppl 3, S368-S376 CrossRef PubMed
5. Renström, E., Barg, S., Thévenod, F. and Rorsman, P. (2002) Sulfonylurea-mediated stimulation of insulin exocytosis via an ATP-sensitive K+ channel-independent action. Diabetes 51 Suppl 1, S33-S36 CrossRef PubMed
6. Zhang, C.L., Katoh, M., Shibasaki, T., Minami, K., Sunaga, Y., Takahashi, H., Yokoi, N., Iwasaki, M., Miki, T. and Seino, S. (2009) The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs. Science 325, 607-610 CrossRef PubMed
7. Ashcroft, F.M. (1988) Adenosine 5'-triphosphate-sensitive potassium channels. Annu. Rev. Neurosci. 11, 97-118 CrossRef PubMed
8. Shyng, S. and Nichols, C.G. (1997) Octameric stoichiometry of the KATP channel complex. J. Gen. Physiol. 110, 655-664 CrossRef PubMed
9. Tucker, S.J., Gribble, F.M., Zhao, C., Trapp, S. and Ashcroft, F.M. (1997) Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor. Nature 387, 179-183 CrossRef PubMed
10. Aittoniemi, J., Fotinou, C., Craig, T.J., de Wet, H., Proks, P. and Ashcroft, F.M. (2009) SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator. Phil. Trans. Royal Soc. Lond. 364, 257-267 CrossRef
11. Zingman, L.V., Alekseev, A.E., Bienengraeber, M., Hodgson, D., Karger, A.B., Dzeja, P.P. and Terzic, A. (2001) Signalling in channel/enzyme multimers: ATPase transitions in SUR module gate ATP-sensitive K+ conductance. Neuron 31, 233-245 CrossRef PubMed
12. Li, L., Geng, X. and Drain, P. (2002) Open state destabilization by ATP occupancy is mechanism speeding burst exit underlying KATP channel inhibition by ATP. J. Gen. Physiol. 119, 105-116 CrossRef PubMed
13. Tarasov, A.I., Girard, C.A. and Ashcroft, F.M. (2006) ATP sensitivity of the ATP-sensitive K+ channel in intact and permeabilized pancreatic beta-cells. Diabetes 55, 2446-2454 CrossRef PubMed
14. Vergani, P., Lockless, S.W., Nairn, A.C. and Gadsby, D.C. (2005) CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains. Nature 433, 876-80 CrossRef PubMed
15. Tsai, M.F., Li, M. and Hwang, T.C. (2010) Stable ATP binding mediated by a partial NBD dimer of the CFTR chloride channel. J. Gen. Physiol. 135, 399-414 CrossRef PubMed
16. Rosenberg, M.F., Callaghan, R., Ford, R.C. and Higgins, C.F. (1997) Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. J. Biol. Chem. 272, 10685-10694 CrossRef PubMed
17. Martin, C., Berridge, G., Mistry, P., Higgins, C., Charlton, P. and Callaghan, R. (2000) Drug binding sites on P-glycoprotein are altered by ATP binding prior to nucleotide hydrolysis. Biochemistry 39, 11901-11906 CrossRef PubMed
18. Vila-Carriles, W.H., Zhao, G. and Bryan, J. (2007) Defining a binding pocket for sulphonylureas in ATP-sensitive potassium channels. FASEB J 21, 18-25 CrossRef PubMed
19. Ashfield, R., Gribble, F.M., Ashcroft, S.J. and Ashcroft, F.M. (1999) Identification of the high-affinity tolbutamide site on the SUR1 subunit of the KATP channel. Diabetes 48, 1341-1347 CrossRef PubMed
20. Kühner, P., Prager, R., Stephan, D., Russ, U., Winkler, M., Ortis, D., Bryan, J. and Quast, U. (2012) Importance of the Kir6.2 N-terminus for the interaction of glibenclamide and repaglinide with the pancreatic KATP channel. Naunyn-Schmiedeberg's Arch. Pharmacol. 385, 299-311 CrossRef
21. Hansen, A.M.K., Hansen, J.B., Carr, R.D., Ashcroft, F.M. and Wahl, P. (2005) Kir6.2-dependent high affinity repaglinide binding to beta-cell KATP channels. Br. J. Pharmacol. 144, 551-557 CrossRef PubMed
22. Gribble, F.M., Tucker, S.J. and Ashcroft, F.M. (1997) The interaction of nucleotides with the tolbutamide block of cloned ATP-sensitive K+ channel currents expressed in Xenopus oocytes: a reinterpretation. J. Physiol. 504, 35-45 CrossRef PubMed
23. Abdelmoneim, A.S., Hasenbank, S.E., Seubert, J.M., Brocks, D.R., Light, P.E. and Simpson, S.H. (2012) Variations in tissue selectivity amongst insulin secretagogues: a systematic review. Diabetes. Obes. Metab. 14, 130-138 CrossRef PubMed
24. Proks, P., de Wet, H. and Ashcroft, F.M. (2010) Activation of the KATP channel by Mg-nucleotide interaction with SUR1. J. Gen. Physiol. 136, 389-405 CrossRef PubMed
25. Proks, P., de Wet, H. and Ashcroft, F.M. (2013) Molecular mechanism of sulphonylurea block of KATP channels carrying mutations that impair ATP inhibition and cause neonatal diabetes. Diabetes 62, 1-11 CrossRef PubMed
26. Trube, G., Rorsman, P. and Ohno-Shosaku, T. (1986) Opposite effects of tolbutamide and diazoxide on the ATP-dependent K-channel in mouse pancreatic beta cells. Pflügers Arch 407, 493-499 CrossRef
27. Lawrence, C.L., Proks, P., Rodrigo, G.C., Jones, P., Hayabuchi, Y., Standen, N.B. and Ashcroft, F.M (2001) Gliclazide produces high-affinity block of KATP channels in mouse isolated pancreatic β-cells but not rat heart or arterial smooth muscle cells. Diabetologia 44, 1019-1025 CrossRef PubMed
28. Zünckler, B.J., Lins, S., Ohno-Shosaku, T., Trube, G. and Panten, U. (1988) Cytosolic ADP enhances the sensitivity of tolbutamide of ATP-dependent K+ channels from pancreatic β-cells. FEBS Lett 239, 241-244 CrossRef PubMed
29. Schwanstecher, C., Dickel, C. and Panten, U. (1992) Cytosolic nucleotides enhance the tolbutamide sensitivity of the ATP-dependent K-channel in mouse pancreatic beta-cells by their combined actions at inhibitory and stimulatory sites. Mol. Pharmacol. 41, 480-486 PubMed
30. Proks, P., de Wet, H. and Ashcroft, F.M. (2014) Sulfonylureas suppress the stimulatory action of Mg-nucleotides on Kir6.2/SUR1 but not Kir6.2/SUR2A KATP channels: A mechanistic study. J. Gen. Physiol. 144, 469-486 CrossRef PubMed
31. Drain, P., Li, L.H. and Wang, J. (1998) KATP channel inhibition by ATP requires distinct functional domains of the cytoplasmic C terminus of the pore-forming subunit. Proc. Natl. Acad. Sci. U.S.A. 95, 13953-13958 CrossRef PubMed
32. Masia, R., Koster, J.C., Tumini, S., Chiarelli, F., Colombo, C., Nichols, C.G. and Barbetti, F. (2007) An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes. Diabetes 56, 328-333 CrossRef PubMed
33. de Wet, H., Mikhailov, M.V., Fotinou, C., Dreger, M., Craig, T.J., Vénien-Bryan, C. and Ashcroft, F.M. (2007) Studies of the ATPase activity of the ABC protein SUR1. FEBS J 274, 3532-3544 CrossRef PubMed
34. Hambrock, A., Löffler-Walz, C. and Quast, U. (2002) Glibenclamide binding to sulphonylurea receptor subtypes: dependence on adenine nucleotides. Br. J. Pharmacol. 136, 995-1004 CrossRef PubMed
35. Venkatesh, N., Lamp, S.T. and Weiss, J.N. (1991) Sulfonylureas, ATP-sensitive K+ channels, and cellular K+ loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle. Circ. Res. 69, 623-637 CrossRef PubMed
36. Ashcroft, F.M. (2010) New uses for old drugs: neonatal diabetes and sulphonylureas. Cell Metab 11, 179-181 CrossRef PubMed
37. Proks, P. and Clark, R. (2015) In ATP-sensitive potassium channels in health and disease. In: Islets of Langerhans (Islam, S., ed.), pp. 305-336, Springer
38. Koster, J.C., Remedi, M.S., Dao, C. and Nichols, C.G. (2005) ATP and sulfonylurea sensitivity of mutant ATP-sensitive K+ channels in neonatal diabetes: implications for pharmacogenomic therapy. Diabetes 54, 2645-2654 CrossRef PubMed
39. Proks, P. (2013) Neonatal diabetes caused by activating mutations in the sulphonylurea receptor. Diabetes Metab. J. 37, 157-164 CrossRef PubMed
40. Flanagan, S.E., Edghill, E.L., Gloyn, A.L., Ellard, S. and Hattersley, A.T. (2006) Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 49, 1190-1197 CrossRef PubMed
41. Drain, P. (2013) ATP and sulfonylurea linkage in the KATP channel solves a diabetes puzzler. Diabetes 62, 3666-3668 CrossRef PubMed
42. Proks, P., Girard, C., Haider, S., Gloyn, A.L., Hattersley, A.T., Sansom, M.S. and Ashcroft, F.M. (2005) A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome. EMBO Rep 6, 470-475 CrossRef PubMed
43. Ortiz, D., Voyvodic, P., Gossack, L., Quast, U. and Bryan, J. (2012) Two neonatal diabetes mutations on transmembrane helix 15 of SUR1 increase affinity for ATP and ADP at nucleotide binding domain 2. J. Biol. Chem. 287, 17985-17895 CrossRef PubMed
44. Dabrowski, M., Wahl, P., Holmes, W.E. and Ashcroft, F.M. (2001) Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels. Diabetologia 44, 747-756 CrossRef PubMed
45. Shibasaki, T., Takahashi, T., Takahashi, H. and Seino, S. (2014) Cooperation between cAMP signalling and sulfonylurea in insulin secretion. Diabetes Obes. Metab. 16 Suppl 1, S118-S125 CrossRef